Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Outstanding
Ratios

Fresenius Medical Care AG (FMS) Receivables Refunds (2016 - 2024)

Historic Receivables Refunds for Fresenius Medical Care AG (FMS) over the last 11 years, with Q4 2024 value amounting to $265.7 million.

  • Fresenius Medical Care AG's Receivables Refunds rose 2510.92% to $265.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $265.7 million, marking a year-over-year increase of 2510.92%. This contributed to the annual value of $265.7 million for FY2024, which is 2510.92% up from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Receivables Refunds of $265.7 million as of Q4 2024, which was up 2510.92% from $212.4 million recorded in Q4 2023.
  • In the past 5 years, Fresenius Medical Care AG's Receivables Refunds ranged from a high of $265.7 million in Q4 2024 and a low of $146.7 million during Q4 2022
  • Moreover, its 5-year median value for Receivables Refunds was $202.7 million (2021), whereas its average is $197.9 million.
  • Its Receivables Refunds has fluctuated over the past 5 years, first tumbled by 3006.52% in 2020, then surged by 4478.85% in 2023.
  • Fresenius Medical Care AG's Receivables Refunds (Quarter) stood at $162.2 million in 2020, then rose by 24.93% to $202.7 million in 2021, then dropped by 27.61% to $146.7 million in 2022, then soared by 44.79% to $212.4 million in 2023, then increased by 25.11% to $265.7 million in 2024.
  • Its Receivables Refunds was $265.7 million in Q4 2024, compared to $212.4 million in Q4 2023 and $146.7 million in Q4 2022.